Mixed connective tissue disease natural history, complications and prognosis: Difference between revisions
(Created page with "__NOTOC__ {{Mixed connective tissue disease}} {{CMG}}; {{AE}} ==Overview== If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1]...") |
|||
Line 22: | Line 22: | ||
===Complications=== | ===Complications=== | ||
*Common complications of | *Common complications of MCTD include:<ref name="pmid24461387">{{cite journal |vauthors=Tani C, Carli L, Vagnani S, Talarico R, Baldini C, Mosca M, Bombardieri S |title=The diagnosis and classification of mixed connective tissue disease |journal=J. Autoimmun. |volume=48-49 |issue= |pages=46–9 |date=2014 |pmid=24461387 |doi=10.1016/j.jaut.2014.01.008 |url=}}</ref> | ||
** | **Polyarthritis | ||
** | **Raynaud's phenomenon | ||
** | **Puffy fingers | ||
**Lung involvement | |||
**Esophageal dysmotility | |||
===Prognosis=== | ===Prognosis=== |
Revision as of 14:39, 27 March 2018
Mixed connective tissue disease Microchapters |
Differentiating Mixed connective tissue disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Mixed connective tissue disease natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Mixed connective tissue disease natural history, complications and prognosis |
FDA on Mixed connective tissue disease natural history, complications and prognosis |
on Mixed connective tissue disease natural history, complications and prognosis |
Mixed connective tissue disease natural history, complications and prognosis in the news |
Blogs onMixed connective tissue disease natural history, complications and prognosis |
Directions to Hospitals Treating Mixed connective tissue disease |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
OR
Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
- The symptoms of (disease name) typically develop ___ years after exposure to ___.
- If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
Complications
- Common complications of MCTD include:[1]
- Polyarthritis
- Raynaud's phenomenon
- Puffy fingers
- Lung involvement
- Esophageal dysmotility
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
- Depending on the extent of the [tumor/disease progression/etc.] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
References
- ↑ Tani C, Carli L, Vagnani S, Talarico R, Baldini C, Mosca M, Bombardieri S (2014). "The diagnosis and classification of mixed connective tissue disease". J. Autoimmun. 48-49: 46–9. doi:10.1016/j.jaut.2014.01.008. PMID 24461387.